N-hydroxy-N '-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxybenzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine

Philipp Saiko, Maria Ozsvar-Kozma, Astrid Bernhaus, Margit Jaschke, Geraldine Graser, Andreas Lackner, Michael Grusch, Zsuzsanna Horvath, Sibylle Madlener, Georg Krupitza, Norbert Handler, Thomas Erker, Walter Jäger, Monika Fritzer-Szekeres, Thomas Szekeres

    Publications: Contribution to journalArticlePeer Reviewed

    Fingerprint

    Dive into the research topics of 'N-hydroxy-N '-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxybenzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science